Results 181 to 190 of about 18,058,309 (312)

A Fish MDA5 Integrates Canonical RIG‐I and MDA5 Ligand Recognition

open access: yesAdvanced Science, EarlyView.
These results show that the large yellow croaker lacks RIG‐I, yet its MDA5 senses both 5′ppp‐dsRNA and long dsRNA. A flexible RNA‐capping loop in the MDA5 C‐terminal domain enables two ligand‐binding modes. This dual recognition signals through MAVS–STING–TBK1/IRF3 and induces type I interferons, revealing unexpected plasticity in vertebrate antiviral ...
Wenxing Li   +7 more
wiley   +1 more source

Vaccine Development in Canada [PDF]

open access: yesCanadian Journal of Infectious Diseases and Medical Microbiology, 1993
openaire   +3 more sources

An Oral Antiviral Combination Against Severe COVID‐19 Enabled by the Synergistic Mechanisms of Action of Auranofin and Remdesivir

open access: yesAdvanced Science, EarlyView.
FDA‐approved anti‐inflammatory drug Auranofin inhibits SARS‐CoV‐2 replication by inhibiting viral Main protease activity and Spike processing required for viral entry. It shows strong synergy with nucleoside analogue Remdesivir, due to non‐overlapping mechanisms.
Oyahida Khatun   +13 more
wiley   +1 more source

Advancements in Syphilis Vaccine Development. [PDF]

open access: yesSex Transm Dis
Giacani L   +4 more
europepmc   +1 more source

Human respiratory syncytial virus (RSV) vaccine

open access: yes, 2015
[[abstract]]The present invention relates to a vaccine composition against the infection of human respiratory syncytial virus (RSV) comprising a replication-defective recombinant adenovirus carrying a nucleotide sequence encoding the F protein of RSV or ...
Chow, YH;Shao, HY;Sia, C;Chong, P
core  

In Vivo CRISPR Screen Identifies RPS19 as an Immunotherapy Target in Hepatocellular Carcinoma

open access: yesAdvanced Science, EarlyView.
By employing in vivo CRISPR functional screening, we identify ribosomal protein RPS19 as a pivotal mediator driving immune evasion in hepatocellular carcinoma, wherein tumor‑released RPS19 binds C5aR1 on tumor‑associated macrophages to initiate downstream immunosuppressive signaling; SP94‑peptide‑modified SNPSS nanoparticles deliver Cas9/sgRPS19 ...
Lei He   +20 more
wiley   +1 more source

Immunotherapy and Vaccine Development

open access: yesJournal of Immunology Research, 2018
Leung, Carol   +2 more
openaire   +5 more sources

Combined Immune‐Peptide Nanofiber with HSP70/AKT/mTOR Axis Blockade Enhances Photothermal Immunotherapy, Inhibiting Tumor Growth and Recurrence

open access: yesAdvanced Science, EarlyView.
A carrier‐free peptide‐guided PSP@IR‐CF3 nanofiber system integrates PD‐L1 targeting and photothermal immunotherapy for enhanced cancer treatment. By revealing PTIT‐induced activation of the HSP70/AKT/mTOR pathway and incorporating mTOR inhibition, this strategy effectively overcomes therapeutic resistance and prevents tumor recurrence, providing a ...
Xinyu Zhang   +11 more
wiley   +1 more source

Establishment of a Neonatal Natural Transmission Model for Cytomegalovirus Vaccine Development. [PDF]

open access: yesJ Infect Dis
Jihad T   +20 more
europepmc   +1 more source

Micro- and nanotechnology in vaccine development /

open access: yes
This book provides a comprehensive overview of how use of micro- and nanotechnology (MNT) has allowed major new advance in vaccine development research, and the challenges that immunologists face in making further progress.Online resource; title from PDF
Toth, Istvan,editor.   +1 more
core  

Home - About - Disclaimer - Privacy